Figure S11 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934659.v1
M
Mabel C. Bush
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
80
Citations
3
h-index
2
i10-index
Mabel C. Bush is an academic researcher from Rapt Therapeutics (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 3, co-authored 54 publications.
ORCID: 0000-0001-8494-1294Papers by this author
worksFigure S12 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934656.v1
Figure S4 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934626
Figure S13 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934653.v1
Figure S3 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934629
Table S8 from HPN328, a Trispecific T Cell–Activating Protein Construct Targeting DLL3-Expressing Solid Tumors
2024 · 0 citations
https://doi.org/10.1158/1535-7163.26934581.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat